There is growing interest in refining methods for predicting prognosis in colorectal cancer based on the particular genotypical characteristics of individual tumours.' Furthermore, it has recently been suggested that the clinical courses of hereditary and sporadic cancers may differ, 23 and prolonged survival has been proposed as a feature of the 'cancer family syndrome.'2A To improve the stratification of patients into risk categories and subgroups for treatment, a knowledge of the family history may be advised.235 Because current evidence is based predominantly on patients referred to specialist centres, and in some instances on unsubstantiated family histories,5 however, the finding of improved survival in some reported cases of familial bowel cancer may be unrepresentative of the overall pattern.
The objective of this study was to determine whether the prognosis differed between familial and non-familial colorectal cancer in a population based sample of all histologically diagnosed cases in Northern Ireland. Tables II and III show the results of the univariate log rank survival analysis. (Although the family history variable has been categorised somewhat arbitrarily for this purpose, the raw score is subsequently used in the Cox's multivariate analysis.) The only variable taken alone that was significantly predictive of survival was the pathological stag'e of the index tumour.
Methods
The relation between covariates was investigated using simple crosstabulations. Ofthe many possible bivariate associations, three were statistically significant as follows:
(1) Men had a greater proportion of rectal cancer,X2=8 9, p<001; (2) Younger patients tended to have an excess Prognosis infamilial non-polyposis colorectal cancer X2= 18'3, p<001; (3) Rectal tumours accounted for a greater proportion of the advanced cancers, x2=l2 9 p<O.O5.
The effect of familiality on survival is estimated in the Cox's model by the relative hazards shown in Table IV . As covariates are included in the model their possible confounding effects on the family history relative hazard are successively accounted for.
The relative hazard for familial cases is 10 to 20% higher than for non-familial cases. This is so even after accounting for age, sex, site, or duration of symptoms. When tumour stage is added to the model the excess relative hazard for familial cases disappears. This is because the familial cases tended to have later stage tumours: (48% of cases who had at least one affected relative had stage C or D cancers as opposed to 35% of those with no affected kin). The confidence intervals for the relative hazard include unity every case and so one must conclude that no independent effect offamiliality on prognosis can be shown from these data. cancer. 
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